[
    {
        "file_name": "BIOAMBERINC_04_10_2013-EX-10.34-DEVELOPMENTAGREEMENT(1).txt",
        "perturbation": [
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "2.1 Bioamber shall pay Cargill Two Hundred Fifty Thousand U.S. Dollars ($250,000.00) within thirty (30) days of the execution of this  Development Agreement.",
                "changed_text": "2.1 Bioamber shall pay Cargill Two Hundred Fifty Thousand U.S. Dollars ($250,000.00) within sixty (60) days of the execution of this  Development Agreement.",
                "explanation": "Extended payment terms beyond standard commercial practices may create inconsistencies, especially in jurisdictions with prompt payment laws or industry norms for shorter payment cycles, increasing the risk of disputes.",
                "contradicted_law": "Breach of Contract Law (potentially, depending on jurisdiction and industry standards)",
                "location": "Section 2.1"
            },
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "Milestone 1: Proof of Concept   12 months after Effective Date   US $250,000.00 Milestone 2: CB1 Strain Development   30 months after Effective Date   US $300,000.00 Milestone 3: CB1 Strain Optimization   42 months after Effective Date   US $500,000.00",
                "changed_text": "Milestone 1: Proof of Concept   24 months after Effective Date   US $250,000.00 Milestone 2: CB1 Strain Development   48 months after Effective Date   US $300,000.00 Milestone 3: CB1 Strain Optimization   60 months after Effective Date   US $500,000.00",
                "explanation": "Lengthening project milestones with no clear justification could raise concerns about good faith performance, especially if standard timelines are shorter in the relevant biotechnology sector.",
                "contradicted_law": "Breach of Contract Law (implied duty of good faith and fair dealing)",
                "location": "Section 2.3"
            },
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "5.2.4 If Cargill waives its option to prepare and prosecute a patent application in accordance with Section 5.2.3 and elects not to file such  a patent application or elects to allow any such patent application or issued/granted patent to become abandoned or lapse, Cargill  shall give Bioamber notice of such election promptly and at least two (2) months prior to the first date that action must be taken to  avoid such abandonment or lapse.",
                "changed_text": "5.2.4 If Cargill waives its option to prepare and prosecute a patent application in accordance with Section 5.2.3 and elects not to file such  a patent application or elects to allow any such patent application or issued/granted patent to become abandoned or lapse, Cargill  shall give Bioamber notice of such election at least one (1) week prior to the first date that action must be taken to  avoid such abandonment or lapse.",
                "explanation": "Reducing the notification period for patent abandonment from two months to one week may be considered commercially unreasonable, especially given the complexities of patent prosecution and the time needed for Bioamber to take over the application. This could be seen as a breach of the duty of good faith.",
                "contradicted_law": "Breach of Contract Law (implied duty of good faith and fair dealing)",
                "location": "Section 5.2.4"
            }
        ]
    }
]